Zocere is developing novel therapeutics for destructive neurological diseases, including stroke.
APRINOIA Thera eutics
APRINOIA Therapeutics is a clinical-stage biotechnology company committed to developing highly sensitive and selective diagnostic and therapeutic agents for a broad range of neurodegenerative diseases.